Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
Public ClinicalTrials.gov record NCT01811368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Use of Zevalin to Enhance the Efficacy of Non-Myeloablative Allogeneic Transplantation in Patients With Relapsed or Refractory CD20+ Non-Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT01811368
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Joseph Tuscano
- Other
- Enrollment
- 20 participants
Conditions and interventions
Interventions
- allogeneic hematopoietic stem cell transplantation Procedure
- anti-thymocyte globulin Biological
- cyclosporine Drug
- ibritumomab tiuxetan Biological
- mycophenolate mofetil Drug
- peripheral blood stem cell transplantation Procedure
- rituximab Biological
- total nodal irradiation Radiation
Procedure · Biological · Drug + 1 more
Eligibility (public fields only)
- Age range
- 19 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 11, 2013
- Primary completion
- Mar 31, 2023
- Completion
- Nov 30, 2023
- Last update posted
- Nov 29, 2022
2013 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Davis | Sacramento | California | 95817 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01811368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 29, 2022 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01811368 live on ClinicalTrials.gov.